ES2135463T3 - Inversion de la resistencia multi-medicamento por medio de derivados de trifenil-piperidina. - Google Patents

Inversion de la resistencia multi-medicamento por medio de derivados de trifenil-piperidina.

Info

Publication number
ES2135463T3
ES2135463T3 ES93903678T ES93903678T ES2135463T3 ES 2135463 T3 ES2135463 T3 ES 2135463T3 ES 93903678 T ES93903678 T ES 93903678T ES 93903678 T ES93903678 T ES 93903678T ES 2135463 T3 ES2135463 T3 ES 2135463T3
Authority
ES
Spain
Prior art keywords
integer
tumors
triphenyl
investment
drug resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93903678T
Other languages
English (en)
Inventor
Jules Freedman
Sai P Sunkara
Frank P Palopoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2135463T3 publication Critical patent/ES2135463T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN COMPUESTO DE FORMULA (1) EN DONDE PH1, PH2, Y PH3 SON CADA UNO UN GRUPO FENILO OPCIONALMENTE SUSTITUIDO CON UNA COMBINACION DE MAS DE TRES MIEMBROS DEL GRUPO CONSISTENTE EN FLUOR, CLORO, BROMO, HIDROXI, TRIFLUOROMETILO, NH2, N(CH3)2, ALQUILO (C1 TITUIDO CON UN GRUPO METILENODIOXILO; N ES UN NUMERO ENTERO DESDE 1 A 5; M ES 0 O UN NUMERO ENTERO DE 1 A 2; Y Q ES UN NUMERO ENTERO DE 1 A 2; O UNA SAL DEL MISMO DE ADICION ACIDA QUE INVIERTE LA RESISTENCIA A MULTIPLES MEDICAMENTOS EN CELULAS TUMOROSAS RESISTENTES A MULTIPLES MEDICAMENTOS Y POR ESO ES UTIL ADYUVANTE EN EL TRATAMIENTO DE TUMORES. ESTOS COMPUESTOS APARENTEMENTE FUNCIONAN INHIBIENDO UNA POMPA DE P-GLICOPROTEINA QUE SE VUELVE ACTIVA EN LA ULTIMA ETAPA DEL DESARROLLO DEL TUMOR Y QUE ESTA INHERENTEMENTE PRESENTE EN TUMORES DE CIERTOS ORIGENES.
ES93903678T 1992-02-06 1993-01-11 Inversion de la resistencia multi-medicamento por medio de derivados de trifenil-piperidina. Expired - Lifetime ES2135463T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83254092A 1992-02-06 1992-02-06

Publications (1)

Publication Number Publication Date
ES2135463T3 true ES2135463T3 (es) 1999-11-01

Family

ID=25261950

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93903678T Expired - Lifetime ES2135463T3 (es) 1992-02-06 1993-01-11 Inversion de la resistencia multi-medicamento por medio de derivados de trifenil-piperidina.

Country Status (14)

Country Link
EP (1) EP0643693B1 (es)
JP (1) JPH07503957A (es)
KR (1) KR950700248A (es)
AT (1) ATE182582T1 (es)
AU (1) AU662602B2 (es)
CA (1) CA2129144C (es)
DE (1) DE69325805T2 (es)
DK (1) DK0643693T3 (es)
ES (1) ES2135463T3 (es)
GR (1) GR3031557T3 (es)
HU (1) HUT70564A (es)
NO (1) NO942920L (es)
NZ (1) NZ249040A (es)
WO (1) WO1993016044A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100377280B1 (ko) * 1993-01-21 2003-07-18 메렐 파마슈티칼스 인크. 디아릴알킬피페리딘을함유하는다중-약물내성종양치료효력증강용약제학적조성물
US5670521A (en) * 1994-08-05 1997-09-23 Merrell Pharmaceuticals Inc. Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives
EP1129707A3 (en) 1994-08-31 2002-02-27 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Methods for identifying and treating resistant tumors
TW527186B (en) 1996-03-19 2003-04-11 Janssen Pharmaceutica Nv Fused imidazole derivatives as multidrug resistance modulators
GB0003685D0 (en) * 2000-02-17 2000-04-05 Univ Cardiff Sensitisation of cellular material
CN110372571B (zh) * 2018-04-12 2022-11-15 中国科学院大连化学物理研究所 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1049377B (de) * 1952-04-03 1959-01-29 Abbott Laboratories, North Chicago, 111. (V. St. A.) Verfahren zur Herstellung von substituierten Vinylpiperidinen
EP0235463A3 (en) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents
CA2059127A1 (en) * 1989-06-19 1990-12-20 Oscar William Lever Medicaments useful in cancer therapy and having antihistaminic properties
GB9000305D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Anticholinergic agents
EP0467435A3 (en) * 1990-07-19 1992-04-01 Akzo N.V. Benzhydryl derivatives having calmodulin inhibitor properties
KR100377280B1 (ko) * 1993-01-21 2003-07-18 메렐 파마슈티칼스 인크. 디아릴알킬피페리딘을함유하는다중-약물내성종양치료효력증강용약제학적조성물

Also Published As

Publication number Publication date
WO1993016044A1 (en) 1993-08-19
KR950700248A (ko) 1995-01-16
DK0643693T3 (da) 1999-11-29
AU3484293A (en) 1993-09-03
DE69325805D1 (de) 1999-09-02
NO942920L (no) 1994-08-05
ATE182582T1 (de) 1999-08-15
HUT70564A (en) 1995-10-30
HU9402298D0 (en) 1994-10-28
EP0643693A1 (en) 1995-03-22
CA2129144A1 (en) 1993-08-19
GR3031557T3 (en) 2000-01-31
NO942920D0 (es) 1994-08-05
DE69325805T2 (de) 2000-03-16
EP0643693B1 (en) 1999-07-28
JPH07503957A (ja) 1995-04-27
NZ249040A (en) 1997-06-24
AU662602B2 (en) 1995-09-07
CA2129144C (en) 1999-07-13

Similar Documents

Publication Publication Date Title
NO2014022I1 (no) Rosuvastatin (som sink) og ezetimib
ATE334973T1 (de) Chinazolinverbindungen
FI913503A (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
AR026605A1 (es) Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos
AR020250A1 (es) Compueto de isoxazolinona, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion
DE60127845D1 (de) Benzylidenthiazolidindione und ihre verwendung als antimykotische mittel
AR035756A1 (es) Uso de carbamatos en la preparacion de medicamentos para la prevencion o tratamiento de trastornos neurodegenerativos
ES2135463T3 (es) Inversion de la resistencia multi-medicamento por medio de derivados de trifenil-piperidina.
CO5261527A1 (es) Eteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina
DE69130326D1 (de) Piperidin-verbindungen, ihre darstellung und ihre verwendung
TR200400237T4 (tr) Yeni karışımlar.
SE8503415D0 (sv) Novel isoindolinyl-alkyl-piperazines
DK0714387T3 (da) Hidtil ukendte bis-naphthalimider til behandling af cancer
ATE44648T1 (de) Antihypertensives kombinationspraeparat.
ATE401329T1 (de) Neue antivirale makrocyclische derivate und metallkomplexe, in die verbrückte makrocyclen eingebaut sind
KR960700230A (ko) 다중-약물 내성종양 제제로서 유용한 디아릴알킬 피페리딘(Diarylalkyl piperidines useful as multi-drug resistant tumor agents)
NO963213L (no) Endotelinreseptorantagonister
ATE266026T1 (de) Benzofurancarboxamide und deren therapeutische verwendung
DK1592303T3 (da) Behandling af slam eller opslæmninger
DK0440324T3 (da) Substiturede alfa-diketoner og deres anvendelse til behandling af inflammatorisk tarmsygdom
DE60237652D1 (de) Variolinderivate und ihre Verwendung als Cytostatika
DE69217148D1 (de) Isoxazole derivate als lichtschutzmittel
FI872110A0 (fi) Antihypertensiviska aemnen, dessa innehaollande farmaceutiska blandningar och foerfarande foer framstaellning av aemnen och blandningar.
DK1406607T3 (da) Anvendelse af en klasse antivirale forbindelser til at fremstille et stof til at behandle eller forhindre en virusinfektion i luftvejene
EA200300460A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ м-АМИНОФЕНИЛИМИНОИМИДАЗОЛИДИНА ДЛЯ ЛЕЧЕНИЯ НЕДЕРЖАНИЯ МОЧИ

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 643693

Country of ref document: ES